Application of MultiStem(®) Allogeneic Cells for Immunomodulatory Therapy: Clinical Progress and Pre-Clinical Challenges in Prophylaxis for Graft Versus Host Disease

The last decade has seen much progress in adjunctive cell therapy for immune disorders. Both corporate and institutional Phase III studies have been run using mesenchymal stromal cells (MSC) for treatment of Graft versus Host Disease (GvHD), and product approval has been achieved for treatment of pe...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaes, Bart, Van’t Hof, Wouter, Deans, Robert, Pinxteren, Jef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2012
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506828/
https://www.ncbi.nlm.nih.gov/pubmed/23205020
http://dx.doi.org/10.3389/fimmu.2012.00345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3506828/
https://www.ncbi.nlm.nih.gov/pubmed/23205020
http://dx.doi.org/10.3389/fimmu.2012.00345

Ejemplares similares